Education / Graduate Medical Education / Prospective Fellows / Infectious Diseases Fellowship / Research / Peer Reviewed Publications Recent Peer Reviewed Publications Li JZMelberg MKittilson AAbdel-Mohsen MLi YAga EBosch RJWonderlich ERKinslow JGiron LBDi Germanio CPilkinton MMacLaren LKeefer MFox LBarr LAcosta EAnanworanich JCoombs RMellors JDeeks SGandhi RTBusch MLanday AMacatangay BSmith DM Predictors of HIV rebound differ by timing of antiretroviral therapy initiation.; JCI insight; Vol 9(3). 2024 Feb 08. Miner MDdeCamp AGrunenberg NDe Rosa SCFiore-Gartland ABar KSpearman PAllen MYu PCManso BFrahm NKalams SBaden LKeefer MCScott HMNovak RVan Tieu HTomaras GDKublin JGMcElrath MJCorey LFrank I Polytopic fractional delivery of an HIV vaccine alters cellular responses and results in increased epitope breadth in a phase 1 randomized trial.; EBioMedicine; Vol 100, pp. 104987. 2024 Feb 01. Luther VPParas MLSchultz SAziz MBalba GMcCarty TPRazonable RRReece RShnekendorf RSundareshan VChirch LM High-Volume, High-Acuity, and High-Impact Learning: Tips and Tricks for Infectious Diseases Training Programs.; Open forum infectious diseases; Vol 11(3), pp. ofae016. 2024 Jan 08. Rick AMLaurens MBHuang YYu CMartin TCSRodriguez CARostad CAMaboa RMBaden LREl Sahly HMGrinsztejn BGray GEGay CLGilbert PBJanes HEKublin JGHuang YLeav BHirsch IStruyf FDunkle LMNeuzil KMCorey LGoepfert PAWalsh SRFollmann DKotloff KL Risk of COVID-19 after natural infection or vaccination.; EBioMedicine; Vol 96, pp. 104799. 2023 Sep 20. Rouphael NWinokur PKeefer MCTraenkner JDrobeniuc ADoi YMunsiff SFowler VGEvans SOler RETuyishimire BLee MGhazaryan VChambers HF Daily fosfomycin versus levofloxacin for complicated urinary tract infections.; mBio. 2023 Sep 12. Branche ARRouphael NGDiemert DJFalsey ARLosada CBaden LRFrey SEWhitaker JALittle SJAnderson EJWalter EBNovak RMRupp RJackson LABabu TMKottkamp ACLuetkemeyer AFImmergluck LCPresti RMBäcker MWinokur PLMahgoub SMGoepfert PAFusco DNMalkin EBethony JMWalsh EEGraciaa DSSamaha HSherman ACWalsh SRAbate GOikonomopoulou ZEl Sahly HMMartin TCSKamidani SSmith MJLadner BGPorterfield LDunstan MWald ADavis TAtmar RLMulligan MJLyke KEPosavad CMMeagher MAStephens DSNeuzil KMAbebe KHill HAlbert JTelu KMu JLewis TCGiebeig LAEaton ANetzl AWilks SHTüreli SMakhene MCrandon SMontefiori DCMakowski MSmith DJNayak SURoberts PCBeigel JH Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial.; Nature medicine. 2023 Aug 28. Rouphael NGBranche ARDiemert DJFalsey ARLosada CBaden LRFrey SEWhitaker JALittle SJKamidani SWalter EBNovak RMRupp RJackson LABabu TMKottkamp ACLuetkemeyer AFImmergluck LCPresti RMBäcker MWinokur PLMahgoub SMGoepfert PAFusco DNAtmar RLPosavad CMNetzl ASmith DJTelu KMu JMcQuarrie LJMakowski MMakhene MKCrandon SMontefiori DCRoberts PCBeigel JH Immunogenicity of a Two Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial.; The Journal of infectious diseases. 2023 Aug 10. de Bruyn GWang JPurvis ARuiz MSAdhikarla HAlvi SBonaparte MIBrune DBueso ACanter RMCeregido MADeshmukh SDiemert DFinn AForrat RFu BGallais JGriffin PGrillet MHHaney OHenderson JAKoutsoukos MLaunay OTorres FMMasotti RMichael NLPark JRivera-Medina DMRomanyak NRook CSchuerman LSher LDTavares-Da-Silva FWhittington AChicz RMGurunathan SSavarino SSridhar S Safety and immunogenicity of a variant-adapted SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant as a booster in adults primed with authorized vaccines: a phase 3, parallel-group study.; EClinicalMedicine; Vol 62, pp. 102109. 2023 Jul 22. Falsey ARWalsh EE Respiratory syncytial virus Prefusion F vaccine.; Cell; Vol 186(15), pp. 3137-3137.e1. 2023 Jul 20. Lyke KEAtmar RLDominguez Islas CPosavad CMDeming MEBranche ARJohnston CEl Sahly HMEdupuganti SMulligan MJJackson LARupp RERostad CAColer RNBäcker MKottkamp ACBabu TMDobrzynski DMartin JMBrady RCFrenck RWRajakumar KKotloff KRouphael NSzydlo DPaulChoudhury RArcher JICrandon SIngersoll BEaton ABrown ERMcElrath MJNeuzil KMStephens DSPost DJLin BCSerebryannyy LBeigel JHMontefiori DCRoberts PC Immunogenicity of NVX-CoV2373 heterologous boost against SARS-CoV-2 variants.; NPJ vaccines; Vol 8(1), pp. 98. 2023 Jul 11. Theodore DABranche ARZhang LGraciaa DSChoudhary MHatlen TJOsman RBabu TMRobinson STGilbert PBFollmann DJanes HKublin JGBaden LRGoepfert PGray GEGrinsztejn BKotloff KLGay CLLeav BMiller JHirsch ISadoff JDunkle LMNeuzil KMCorey LFalsey AREl Sahly HMSobieszczyk MEHuang Y Clinical and Demographic Factors Associated With COVID-19, Severe COVID-19, and SARS-CoV-2 Infection in Adults: A Secondary Cross-Protocol Analysis of 4 Randomized Clinical Trials.; JAMA network open; Vol 6(7), pp. e2323349. 2023 Jul 03. Falsey ARBranche ARCroft DPFormica MAPeasley MRWalsh EE Real-Life Assessment of BioFire FilmArray® Pneumonia Panel in Adults Hospitalized with Respiratory Illness.; The Journal of infectious diseases. 2023 Jun 27. Rouphael NGBranche ARDiemert DJFalsey ARLosada CBaden LRFrey SEWhitaker JALittle SJKamidani SWalter EBNovak RMRupp RJackson LABabu TMKottkamp ACLuetkemeyer AFImmergluck LCPresti RMBäcker MWinokur PLMahgoub SMGoepfert PAFusco DNAtmar RLPosavad CMNetzl ASmith DJTelu KMu JMakowski MMakhene MKCrandon SMontefiori DCRoberts PCBeigel JH Immunogenicity of a Two Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial.; medRxiv : the preprint server for health sciences. 2023 Jun 10. Ortega-Villa AMHynes NALevine CBYang KWiley ZJilg NWang JWhitaker JAColombo CJNayak SUKim HJIovine NMInce DCohen SHLanger AJWortham JMAtmar RLEl Sahly HMJain MKMehta AKWolfe CRGomez CABeresnev TMularski RAPaules CIKalil ACBranche ARLuetkemeyer AZingman BSVoell JWhitaker MHarkins MSDavey RTGrossberg RGeorge SLTapson VShort WRGhazaryan VBenson CADodd LESweeney DATomashek KM Evaluating Demographic Representation in Clinical Trials: Use of the Adaptive Coronavirus Disease 2019 Treatment Trial (ACTT) as a Test Case.; Open forum infectious diseases; Vol 10(6), pp. ofad290. 2023 May 27. Ince DFiawoo SChoudhury RCosgrove SEDobrzynski DGold HLee JHPercival KMShulder SSony DSpivak ESTamma PDNori P Epidemiology of Gram-Negative Bloodstream Infections in the United States: Results From a Cohort of 24 Hospitals.; Open forum infectious diseases; Vol 10(7), pp. ofad265. 2023 May 22.